文献速递脑血管病外科神经重症

脑动静脉畸形栓塞围手术期颅内出血的荟萃分析

Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis.
PubMed 文献 · J Neurosurg · 2019-09-13

该荟萃分析纳入1990至2019年间98项研究共8009例脑动静脉畸形患者,评估液体栓塞后30天内围手术期出血率。每例次手术总出血率为2.6%,每例患者为4.8%,出血相关死亡率和致残率分别为14.6%和45.1%。辅助性栓塞的出血率低于治愈性栓塞,治疗动脉瘤和更大样本量是低出血率的预测因素。

要点

  • 脑动静脉畸形液体栓塞后每例次手术围手术期出血率为2.6%,每例患者为4.8%。
  • 出血相关死亡率和致残率分别为14.6%和45.1%。
  • 辅助性栓塞出血率低于治愈性栓塞,治疗动脉瘤与更低出血率相关。

核心结论

  • 脑动静脉畸形经动脉栓塞后每例次手术围手术期出血率为2.6%,每例患者为4.8%。
  • 辅助性栓塞包括治疗动脉瘤及术前或放疗前栓塞是更低出血率的研究水平预测因素。
  • 治愈性栓塞和血管内造影闭塞是更高总出血率的研究水平预测因素。

研究设计与样本

  • 研究检索1990至2019年PubMed和Embase数据库,纳入报告液体栓塞后30天内围手术期出血的研究。
  • 共纳入98项研究、8009例患者,平均每例患者栓塞1.9次。
  • 采用随机效应荟萃分析评估出血率,并用荟萃回归分析研究水平预测因素。

主要发现

  • 每例次手术血流相关和总围手术期出血率分别为2.0%(95%CI 1.5%-2.4%)和2.6%(95%CI 2.1%-3.0%)。
  • 每例患者血流相关和总围手术期出血率分别为3.4%(95%CI 2.6%-4.2%)和4.8%(95%CI 4.0%-5.6%)。
  • 出血相关死亡率和致残率分别为14.6%和45.1%。
  • 每例次手术总出血率在辅助性栓塞为1.8%(95%CI 1.0%-2.5%),治愈性栓塞为4.6%(95%CI 2.8%-6.4%)。
  • 治疗动脉瘤(p=0.04)和更大患者人群(p<0.001)是更低出血率的显著预测因素;治愈性意图(p=0.04)、血管内造影闭塞(p=0.003)和更多栓塞次数(p=0.03)是更高出血率的显著预测因素。

关键数值与推荐

  • 围手术期出血定义为液体栓塞后30天内发生的出血。
  • 血流相关出血指归因于脑动静脉畸形血流动力学改变的出血,技术性出血指与操作并发症相关的出血。
  • 栓塞材料为氰基丙烯酸酯或乙烯-乙烯醇共聚物。

临床怎么用

  • 栓塞前应评估治愈性意图和血管内闭塞目标对应的围手术期出血风险。
  • 对合并动脉瘤的脑动静脉畸形,治疗动脉瘤可能与更低出血率相关。
  • 辅助性栓塞(术前或放疗前)的出血率低于治愈性栓塞,可用于风险分层沟通。

局限性

  • 本研究为研究水平荟萃分析,非患者个体数据。
  • 未发现出血率随研究年份或栓塞材料不同而有显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The primary goal of the treatment of cerebral arteriovenous malformations (AVMs) is angiographic occlusion to eliminate future hemorrhage risk. Although multimodal treatment is increasingly used for AVMs, periprocedural hemorrhage after transarterial embolization is a potential endovascular complication that is only partially understood and merits quantification. METHODS: Searching the period between 1990 and 2019, the authors of this meta-analysis queried the PubMed and Embase databases for studies reporting periprocedural hemorrhage (within 30 days) after liquid embolization (using cyanoacrylate or ethylene vinyl alcohol copolymer) of AVMs. Random effects meta-analysis was used to evaluate the pooled rate of flow-related hemorrhage (those attributed to alterations in AVM dynamics), technical hemorrhage (those related to procedural complications), and total hemorrhage. Meta-regression was used to analyze the study-level predictors of hemorrhage, including patient age, Spetzler-Martin grade, hemorrhagic presentation, embolysate used, intent of treatment (adjuvant vs curative), associated aneurysms, endovascular angiographic obliteration, year of study publication, and years the procedures were performed. RESULTS: A total of 98 studies with 8009 patients were included in this analysis, and the mean number of embolization sessions per patient was 1.9. The pooled flow-related and total periprocedural hemorrhage rates were 2.0% (95% CI 1.5%-2.4%) and 2.6% (95% CI 2.1%-3.0%) per procedure and 3.4% (95% CI 2.6%-4.2%) and 4.8% (95% CI 4.0%-5.6%) per patient, respectively. The mortality and morbidity rates associated with hemorrhage were 14.6% and 45.1%, respectively. Subgroup analyses revealed a pooled total hemorrhage rate per procedure of 1.8% (95% CI 1.0%-2.5%) for adjuvant (surgery or radiosurgery) and 4.6% (95% CI 2.8%-6.4%) for curative intent. The treatment of aneurysms (p = 0.04) and larger patient populations (p < 0.001) were significant predictors of a lower hemorrhage rate, whereas curative intent (p = 0.04), angiographic obliteration achieved endovascularly (p = 0.003), and a greater number of embolization sessions (p = 0.03) were significant predictors of a higher hemorrhage rate. There were no significant differences in periprocedural hemorrhage rates according to the years evaluated or the embolysate utilized. CONCLUSIONS: In this study-level meta-analysis, periprocedural hemorrhage was seen after 2.6% of transarterial embolization procedures for cerebral AVMs. The adjuvant use of endovascular embolization, including in the treatment of associated aneurysms and in the presurgical or preradiosurgical setting, was a study-level predictor of significantly lower hemorrhage rates, whereas more aggressive embolization involving curative intent and endovascular angiographic obliteration was a predictor of a significantly higher total hemorrhage rate.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Subat YW, Dasenbrock HH, Gross BA, et al. Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2019. PMID: 31518979. doi:10.3171/2019.5.JNS183204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。